Menu
GeneBe

20-486411-C-T

Variant summary

Our verdict is Likely benign. Variant got -1 ACMG points: 3P and 4B. PM2PP2BP4_Strong

The NM_177559.3(CSNK2A1):c.1025G>A(p.Gly342Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000031 in 1,613,070 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 31)
Exomes 𝑓: 0.0000021 ( 0 hom. )

Consequence

CSNK2A1
NM_177559.3 missense

Scores

4
10

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.83
Variant links:
Genes affected
CSNK2A1 (HGNC:2457): (casein kinase 2 alpha 1) Casein kinase II is a serine/threonine protein kinase that phosphorylates acidic proteins such as casein. It is involved in various cellular processes, including cell cycle control, apoptosis, and circadian rhythm. The kinase exists as a tetramer and is composed of an alpha, an alpha-prime, and two beta subunits. The alpha subunits contain the catalytic activity while the beta subunits undergo autophosphorylation. The protein encoded by this gene represents the alpha subunit. Multiple transcript variants encoding different protein isoforms have been found for this gene. [provided by RefSeq, Apr 2018]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant where missense usually causes diseases, CSNK2A1
BP4
Computational evidence support a benign effect (MetaRNN=0.048299134).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
CSNK2A1NM_177559.3 linkuse as main transcriptc.1025G>A p.Gly342Asp missense_variant 13/14 ENST00000217244.9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
CSNK2A1ENST00000217244.9 linkuse as main transcriptc.1025G>A p.Gly342Asp missense_variant 13/141 NM_177559.3 P1P68400-1

Frequencies

GnomAD3 genomes
AF:
0.0000132
AC:
2
AN:
151596
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000132
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.00000796
AC:
2
AN:
251306
Hom.:
0
AF XY:
0.00
AC XY:
0
AN XY:
135826
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.0000992
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000880
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000205
AC:
3
AN:
1461356
Hom.:
0
Cov.:
30
AF XY:
0.00
AC XY:
0
AN XY:
727022
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000224
Gnomad4 ASJ exome
AF:
0.0000383
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
9.00e-7
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.0000132
AC:
2
AN:
151714
Hom.:
0
Cov.:
31
AF XY:
0.0000135
AC XY:
1
AN XY:
74072
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.000132
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000422
Hom.:
0
ExAC
AF:
0.00000824
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsMar 06, 2023The c.1025G>A (p.G342D) alteration is located in exon 13 (coding exon 11) of the CSNK2A1 gene. This alteration results from a G to A substitution at nucleotide position 1025, causing the glycine (G) at amino acid position 342 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.37
BayesDel_addAF
Benign
-0.089
T
BayesDel_noAF
Benign
-0.37
Cadd
Benign
21
Dann
Uncertain
0.98
DEOGEN2
Benign
0.33
T;T;T;T;T;.;T;T;.;.;.;T;.;.;.;.;.;T;T
Eigen
Benign
-0.56
Eigen_PC
Benign
-0.40
FATHMM_MKL
Uncertain
0.92
D
M_CAP
Benign
0.022
T
MetaRNN
Benign
0.048
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.34
N;N;N;.;.;.;N;N;.;.;.;N;.;.;.;.;.;N;N
MutationTaster
Benign
1.0
D;D;D;D
PrimateAI
Uncertain
0.55
T
Polyphen
0.047
B;B;B;.;.;.;B;B;.;.;.;B;.;.;.;.;.;B;B
Vest4
0.37, 0.37
MutPred
0.17
Loss of catalytic residue at G342 (P = 0.0236);Loss of catalytic residue at G342 (P = 0.0236);Loss of catalytic residue at G342 (P = 0.0236);.;Loss of catalytic residue at G342 (P = 0.0236);.;Loss of catalytic residue at G342 (P = 0.0236);Loss of catalytic residue at G342 (P = 0.0236);.;.;Loss of catalytic residue at G342 (P = 0.0236);Loss of catalytic residue at G342 (P = 0.0236);.;.;.;.;.;Loss of catalytic residue at G342 (P = 0.0236);Loss of catalytic residue at G342 (P = 0.0236);
MVP
0.67
MPC
0.063
ClinPred
0.19
T
GERP RS
2.0
Varity_R
0.16
gMVP
0.36

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs201877131; hg19: chr20-467055; API